GLP-1 Drugs Cut Addiction Risk and Overdose Deaths Across Six Substances
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
20 articles
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
Scientists found astrocytes, not just neurons, control when you feel full after eating through a newly discovered glucose-sensing pathway.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
A novel ฮฒ2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
New mouse research shows zero-sucrose diets worsened blood sugar, gut bacteria, and liver health โ even on a low-fat diet.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
Chilling cooked potatoes transforms starch into resistant form, dramatically lowering glycemic impact compared to hot potatoes.
A low-calorie fasting diet reduced gum and systemic inflammation markers in periodontitis patients, pointing to diet as a powerful oral health tool.
A new study finds intermittent fasting triggers coordinated changes in gut microbiome and brain regions controlling appetite and cravings.
Stanford study shows fasting-mimicking diet for 5 days monthly improved symptoms in two-thirds of Crohn's patients while reducing inflammation markers.
New research reveals fructose acts as a metabolic signal promoting fat storage, insulin resistance, and chronic disease risk.
A major 6-year European trial found a calorie-reduced Mediterranean diet plus exercise slashed type 2 diabetes risk by nearly a third.
Adding broccoli, vinegar, or lemon juice to potatoes dramatically reduces blood sugar spikes and insulin demand in new research.
Genetic testing for health risks has a 40% false-positive rate and often outperformed by lifestyle factors. Here's what the evidence shows.
A randomized trial finds 6โ7 oz of beef daily caused no worse blood sugar, insulin, or inflammation vs. poultry in prediabetic adults.
A proteomics study tracking 3,000 blood proteins reveals fasting's deepest benefits emerge only after 72 hours without food.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.